These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4073965)

  • 41. [Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
    Honda M; Satoh M; Tujimoto Y; Takada T; Matsumiya K; Fujioka H
    Hinyokika Kiyo; 2006 May; 52(5):331-5. PubMed ID: 16758720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Urinary cytology for the diagnosis and follow-up of tumors of the bladder].
    Salinas Sánchez AS; Sola Pérez J; Tomás Ros M; Server Falgas G
    Actas Urol Esp; 1987; 11(1):47-52. PubMed ID: 3577886
    [No Abstract]   [Full Text] [Related]  

  • 43. Re: Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
    Palou J; Rodríguez O; Segarra J; Rosales A
    J Urol; 2006 Jul; 176(1):407; author reply 407-8. PubMed ID: 16753451
    [No Abstract]   [Full Text] [Related]  

  • 44. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Witjes JA
    Eur Urol; 2009 Apr; 55(4):919. PubMed ID: 18722044
    [No Abstract]   [Full Text] [Related]  

  • 45. Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer.
    Stein JP; Skinner DG
    BJU Int; 2003 Jul; 92(1):12-7. PubMed ID: 12823375
    [No Abstract]   [Full Text] [Related]  

  • 46. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Organ-sparing treatment in muscle-invasive bladder cancer.
    Dunst J; Diestelhorst A; Kühn R; Müller AC; Scholz HJ; Fornara P
    Strahlenther Onkol; 2005 Oct; 181(10):632-7. PubMed ID: 16220401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Herr HW
    Eur Urol; 2009 Apr; 55(4):920-1. PubMed ID: 18722043
    [No Abstract]   [Full Text] [Related]  

  • 49. Intravesical chemotherapy.
    Prout GR
    Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
    [No Abstract]   [Full Text] [Related]  

  • 50. Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments.
    Parekh DJ; Bochner BH; Dalbagni G
    J Clin Oncol; 2006 Dec; 24(35):5519-27. PubMed ID: 17158537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Superficial bladder cancer--problems with selection.
    Glashan RW
    Prog Clin Biol Res; 1985; 185B():13-8. PubMed ID: 4034586
    [No Abstract]   [Full Text] [Related]  

  • 52. [Bladder tumors in patients under 40 years of age].
    Njeh M; Kechaou M; Jeribi M; Mhiri MN
    Ann Urol (Paris); 1994; 28(5):268-9. PubMed ID: 7825985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma.
    Friedrich MG; Pichlmeier U; Schwaibold H; Conrad S; Huland H
    Eur Urol; 2007 Oct; 52(4):1123-29. PubMed ID: 17383080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.
    Chauvet B; Brewer Y; Félix-Faure C; Davin JL; Choquenet C; Reboul F
    J Urol; 1996 Oct; 156(4):1258-62. PubMed ID: 8808849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The results of the surgical treatment of bladder cancer patients].
    Matveev BP; Figurin KM
    Urol Nefrol (Mosk); 1997; (2):25-8. PubMed ID: 9206878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [International Consensus Panel--treatment strategies for superficial bladder cancer].
    Adler S; St Niclas M
    Aktuelle Urol; 2006 Sep; 37(5):320-3; discussion 322-3. PubMed ID: 17004179
    [No Abstract]   [Full Text] [Related]  

  • 57. [Applications for lasers in carcinoma of the urinary bladder].
    Hofstetter A
    Urologe A; 1994 Jul; 33(4):288-90. PubMed ID: 7941173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality control in transurethral resection of bladder tumours.
    Herr HW; Donat SM
    BJU Int; 2008 Nov; 102(9 Pt B):1242-6. PubMed ID: 19035888
    [No Abstract]   [Full Text] [Related]  

  • 60. Up-front intravesical chemotherapy for low stage, low grade recurrent bladder cancer.
    Maffezzini M; Simonato A; Zanon M; Raber M; Carmignani G
    J Urol; 1996 Jan; 155(1):91-3. PubMed ID: 7490907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.